Strategies for Implementing GlobalConsent to Prevent Sexual Violence in University Men
Launched by EMORY UNIVERSITY · May 29, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
The SCALE trial is a research study aimed at preventing sexual violence among university men in Vietnam. It will compare two different strategies for implementing a web-based program called GlobalConsent, which is designed to help reduce sexual violence. The study will look at how well each strategy works, how much they cost, and what factors contribute to their success. By gathering data from six universities in Vietnam, the researchers hope to find the best ways to launch this important program on a larger scale, ultimately improving the safety and health of young men.
To participate in this study, young men aged 18 to 24 who identify as heterosexual or bisexual and are first-year students at one of the six universities can join. Faculty members at these universities can also take part in climate surveys to help provide valuable insights. Participants can expect to be involved in activities that support the implementation of GlobalConsent, contributing to a safer environment on campus. The trial is currently recruiting participants and aims to gather important information that can guide future efforts in sexual violence prevention.
Gender
ALL
Eligibility criteria
- Inclusion Criteria for Students:
- • 18 and older
- • Men who self-identify as heterosexual or bisexual (who are attracted to women),
- • Enrolled as first-year students in any of the seven participating study universities in North, Central, and South Vietnam.
- Exclusion Criteria for Students:
- • Adults unable to consent
- • Individuals who are not yet adults (infants, children, teenagers)
- Inclusion Criteria for Faculty:
- • All registered lecturers at each of the seven participating study universities will be eligible to participate in the faculty surveys in years 1, 3, and 5.
- Exclusion Criteria for Faculty:
- • None
- Inclusion Criteria for Leaders:
- • Recommendation of study staff at each participating study university
- • Knowledge about the implementation landscape and implementation of GlobalConsent.
- Exclusion Criteria for Leaders:
- • None
- Inclusion Criteria for Implementation Teams:
- • Identified by relevant study staff.
- Exclusion Criteria for Implementation Teams:
- • None
About Emory University
Emory University, a leading research institution located in Atlanta, Georgia, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Emory harnesses the expertise of its renowned faculty and state-of-the-art facilities to conduct cutting-edge research across various fields, including oncology, neurology, and infectious diseases. The university's commitment to ethical research practices and patient safety ensures that all clinical trials are designed to generate valuable data that can lead to significant therapeutic advancements. By fostering partnerships with local hospitals and community organizations, Emory strives to translate research findings into real-world applications, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ho Chi Minh City, , Vietnam
Hanoi, , Vietnam
Cần Thơ, , Vietnam
Da Nang, , Vietnam
Huế, , Vietnam
Hải Phòng, , Vietnam
Ho Chi Minh City, , Vietnam
Patients applied
Trial Officials
Kathryn Yount, PhD
Principal Investigator
Emory University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported